Botanical
1 / 5
Momordica charantia, the core active ingredient in our bitter melon extract, is known for its potent hypoglycemic properties. Composed of steroidal glycosides, momordica charantia has insulin-like effects, helping regulate blood sugar levels by enhancing cellular glucose uptake and improving pancreatic beta cell function. Its ability to modulate lipid metabolism also makes it a dual-action ingredient for metabolic health.
Driven by rising diabetes prevalence and a consumer shift toward natural supplements, the global bitter melon extract market is rapidly expanding. The botanical extract sector is projected to experience a compound annual growth rate of 6-8%.
Different from suppliers who use only ethanol extraction, we utilize a hydroalcoholic biphasic process to maximize momordica charantia yield (HPLC-verified) while simultaneously removing heavy metals. Competitors' UV-tested extracts lack the precision required to retain active compounds.
We offer flexible packaging options from 1 kg to 25 kg and support private label customers with custom capsules and tablets. Kosher and halal certifications are available to simplify your compliance process. We guarantee a 24-month shelf life, backed by accelerated degradation studies, to ensure your final product maintains its efficacy.
| Item | Specification | Test Method | Result |
|---|---|---|---|
| Charantin | ≥10% | HPLC | 10.5% |
| Loss on Drying | ≤5.0% | GB/T 5009.3 | 4.2% |
| Ash | ≤5.0% | AOAC 923.03 | 3.8% |
| Heavy Metals | ≤10 ppm | ICP-MS | Complies |
| Pb (Lead) | ≤2 ppm | ICP-MS | <2 ppm |
| Cd (Cadmium) | ≤1 ppm | ICP-MS | <1 ppm |
| As (Arsenic) | ≤1 ppm | ICP-MS | <1 ppm |
| Hg (Mercury) | ≤0.1 ppm | ICP-MS | <0.1 ppm |
| Microbial Total Plate Count | ≤1000 CFU/g | AOAC 990.12 | 450 CFU/g |
| Yeast & Mold | ≤100 CFU/g | AOAC 997.02 | 30 CFU/g |
| Appearance | Brown yellow fine powder | Visual | Complies |
| Solubility | Soluble in water and ethanol | Visual | Complies |
